About the journal
Current Cancer Reports is an open-access journal in Singapore. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- ISSN
- 2661-3166
- Country
- Singapore
- Access
- Open access
- Official website
- https://www.syncsci.com/journal/index.php/CCR
Index listings
- PUBMED · 2020-12-15
- Indexing
- PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
44
Last recorded publication year
2025
h-index
7
i10-index
4
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- PKP PN
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 65%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity1
- Source type
- journal
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cancer survivorship and care
- Cancer survivorship and care
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Cancer Genomics and Diagnostics
- Cancer Immunotherapy and Biomarkers
- Cancer Genomics and Diagnostics
Show all subjects (50)
- Global Cancer Incidence and Screening
- Cancer Risks and Factors
- Economic and Financial Impacts of Cancer
- Lung Cancer Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Global Cancer Incidence and Screening
- Cancer Risks and Factors
- Sarcoma Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Economic and Financial Impacts of Cancer
- Immune cells in cancer
- BRCA gene mutations in cancer
- Ubiquitin and proteasome pathways
- Immune cells in cancer
- Cancer-related Molecular Pathways
- Ocular Diseases and Behçet’s Syndrome
- Medication Adherence and Compliance
- Cardiac tumors and thrombi
- Vascular Tumors and Angiosarcomas
- Multiple and Secondary Primary Cancers
- Gastric Cancer Management and Outcomes
- Prostate Cancer Diagnosis and Treatment
- Ubiquitin and proteasome pathways
- BRCA gene mutations in cancer
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Ocular Diseases and Behçet’s Syndrome
- Gastric Cancer Management and Outcomes
- Cancer-related Molecular Pathways
- Prostate Cancer Diagnosis and Treatment
- Vascular Tumors and Angiosarcomas
- Multiple and Secondary Primary Cancers
- Cardiac tumors and thrombi
- Medication Adherence and Compliance
- Nanoparticle-Based Drug Delivery
- Nanoparticle-Based Drug Delivery
- Bacterial Genetics and Biotechnology
- Bacterial Genetics and Biotechnology
- Hepatocellular Carcinoma Treatment and Prognosis
- Smoking Behavior and Cessation
- Hepatocellular Carcinoma Treatment and Prognosis
- Smoking Behavior and Cessation
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ